Bone lead as a new biologic marker of lead dose: Recent findings and implications for public health

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 4, 1998, Pages 961-967

  Hu, Howard ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone; Cognitive; Hypertension; K X ray fluorescence; Kidney; Lead; Reproductive

Indexed keywords

BIOLOGICAL MARKER; CADMIUM 109; LEAD;

BEHAVIOR DISORDER; BONE LEVEL; COGNITIVE DEFECT; CONFERENCE PAPER; HUMAN; HYPERTENSION; INFERTILITY; INTERMETHOD COMPARISON; KIDNEY FAILURE; LEAD BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; X RAY FLUORESCENCE;

EID: 0031656630     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s4961     Document Type: Conference Paper

References (65)

1. U.S. CDC, Preventing Lead Poisoning in Young Children. Atlanta, GA: Centers for Disease Control and Prevention, 1991.
2. Rempel D. The lead-exposed worker. JAMA 262: 532-534 (1989).
3. Schroeder HA, Tipton IH. The human body burden of lead. Arch Environ Health 17: 965-978 (1968).
4. Barry PSI, Mossman DB. Lead concentrations in human Tissues. Br J Ind Med 27: 339-351 (1970).
5. Landrigan PJ, Todd AC. Direct measurement of lead in bone: a promising biomarker. JAMA 271: 239-240 (1994).
6. Hu H, Milder F, Burger D. X-ray fluorescence: issues surrounding the application of a new tool for measuring lead burden. Environ Res 49: 295-317 (1989).
7. Schutz A, Skerfving S, Ranstam J, Christoffersson J-O. Kinetics of lead in blood after the end of occupational exposure. Scand J Work Environ Health 13: 221-231 (1987).
8. Nilsson U, Attewell R, Christoffersson J-O, Schütz A, Ahlgren L, Skerfving S, Mattsson S. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol Toxicol 69: 477-484 (1991).
9. O'Flaherty KJ. Physiologic changes during growth and development. Environ Health Perspect 102(Suppl 11): 103-106 (1994).
10. Silbergeld EK. Lead in bone: implications for toxicology during pregnancy and lactation. Environ Health Perspect 91: 73-70 (1991).
11. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med 130: 51-62 (1997).
12. Silbergeld HK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 47: 79-94 (1988).
13. Symanski K, Hertz-Picciotto I, Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol 141: 1047-1058 (1995).
14. Webber CK, Chettle OR, Bowins RJ, Beaumont LF, Gordon CI., Song X, Blake JM, McNutt RH. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect 103(12): 1150-1153 (1995).
15. Rabinowitz M. Relating tooth lead and blood lead levels. Bull Environ Contam Tox 55: 853-857 (1985).
16. Hu H, Pepper L, Goldman R. Effect of repeated lead exposure, cessation or exposure, and chelation on levels of lead in bone. Am J Ind Med 20: 723-735 (1991).
17. Tell I, Somervaille LJ, Nilsson U, Bensryd I, Schütz A, Chettle DR, Scott MC, Skerfving S. Chelated lead and bone lead. Scand J Work Environ Health 18: 113-119 (1992).
18. Wedeen RP. In vivo tibial XRF measurement of bone lead. Arch Environ Health 45: 69-71 (1990).
19. Hu H, Aro A, Rotnitzky A. Bone lead measured by X-ray fluorescence: epidemiological methods and a new biomarker. Environ Health Perspect 103(Suppl 1): 105-110 (1995).
20. Rosen JF, Crocetti AF, Balbi K, Balbi J, Bailey C, Clemente I, Redkey N, Grainger S. Bone lead content assessed by L-line x-ray fluorescence in lead-exposed and rion-lead-exposed suburban populations in the United States. Proc Natl Acad Sci USA 90: 2789-2792 (1993).
21. Preiss IL, Tariq MA. On the use of L x-ray fluorescence for bone lead evaluation. J Radioanal Nucl Chem Lett 164: 381-387 (1992).
22. 109Cd. Environ Health Perspect 91: 49-55 (1991).
23. Gordon CL, Chettle DR, Webber CE. An improved instrument for the in vivo detection of lead in bone. Br J Ind Med 50: 637-641 (1993).
24. 109Cd K-X-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol 39: 2263-2271 (1994).
25. Burger D, Morsillo P, Adams B, Hu H, Milder PL. Automated instrument for making K-X-ray fluorescence measurements in human bone. Basic Life Sci 55: 287-293 (1990).
26. Somervaille LJ, Chettle DR, Scott MC. In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol 30: 929-943 (1985).
27. 109Cd sources: radiation dosimetry studies. Environ Res 57: 1 17-132 (1992).
28. Hall EJ. Radiation protection. In: Radiology for the Radiologist. 3rd ed. Philadelphia: Lippincott, 1988,
29. Hu H, Milder F, Burger DE. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposures. Arch Environ Health 45: 335-341 (1990).
30. 109Cd-based X-ray fluorescence measurements of bone lead. Environ Health Perspect 102: 690-694 (1994).
31. Armstrong R, Chettle DR, Scott MC, Somervaille LJ, Pendlington M. Repeated measurements of tibia lead concentrations by in vivo X ray fluorescence in occupational exposure. Br J Ind Med 49: 14-16 (1992).
32. Wittmers LE, Aufderheide A, Wallgren J, Rapp G, Alich A. Lead in bone. IV: Distribution of lead in the human skeleton. Arch Environ Health 43: 381-391 (1988).
33. Hu H, Tosteson T, Aufderheide A, Wittmers L, Burger DE, Milder FL, Schidlovskv G, Jones KW. The distribution of lead in bone. I: Atomic absorption measurements. Basic Life Sci 55: 267-274 (1990).
34. Chettle DR, Scott MC, Somervaille LJ. Improvements in the precision of in vivo bone lead measurements. Phys Med Biol 34: 1295-1300 (1989).
35. Kim R, Landrigan C, Mossman P, Sparrow D, Hu H. Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol 146: 586-591 (1997).
36. Price J, Baddeley H, Kenardy JA, Thomas BJ, Thomas BW. In vivo X-ray fluorescence estimation of bone lead concentrations in Queensland adults. Br J Radiol 57: 29-33 (1984).
37. Kosnett MJ, Becker CE, Osterloh JD, Kelly TJ, Pasta DJ. Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence. JAMA 271: 197-203 (1994).
38. Watanabe H, Hu H, Rotnitzky A. Correlates of bone and blood lead levels in carpenters. Am J Ind Med 26: 255-264 (1994).
39. Hu H, Payton M, Korrick S, Sparrow D, Weiss ST, Aro A, Rotnirzky A. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men: the Normative Aging Study. Am J Epidemiol 144: 749-759 (1996).
40. Shaper AG, Pocock SJ, Walker M, Wale CJ, Clayton B, Delves H, Hinks L. Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J 284: 299-302 (1992).
41. Berode M, Wielisbach V, Rickenbach M, Buillemin MP. Lifestyle and environmental factors as determinants of blood lead levels in a Swiss population. Environ Res 55: 1-17 (1991).
42. Willers S, Schutz A, Attewell R, Skerfving S. Relation between lead and cadmium in blood and the involuntary smoking of children. Scand J Work Environ Health 14: 385-389 (1988).
43. Hoppin JA, Aro A, Hu H, Ryan PB. Validation of K-x-ray fluorescence bone lead measurements in adolescents. Environ Health Perspect 103: 78-83 (1995).
44. Hu H, Hashimoto D, Besser M. Levels of lead in blood and bone of women giving birth in a Boston hospital. Arch Environ Health 51: 52-58 (1996).
45. Morgan WD, Ryde SJS, Jones SJ, Wyart RM, Hainsworth IR, Cobbold SS, Evans CJ, Braithwaite RA. In vivo measurements of cadmium and lead in occupationally-exposed workers and an urban population. Biol Trace Elem Res 26-27: 407-414 (1990).
46. Roy MM, Gordon CL, Beaumont LF, Chettle DR, Webber CE. Further experience with bone lead content measurements in residents of southern Ontario. Appl Radiat Isot 48: 391-396 (1997).
47. Barry PSI, Mossman DB. Lead concentrations in human tissues. Br J Ind Med 27: 330-351 (1970).
48. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106: 1-8 (1998).
49. Hernandez-Avila M, González-Cossio T, Palazuelos E, Romieu I, Aro A, Fishbein E, Hu H. Dietary and environmental determinants of blood and bone lead levels in a pilot study of postpartum women in Mexico City. Environ Health Perspect 104: 1076-1082 (1996).
50. Farias P, Hu H, Runenstein K, Meneses-Gonzalez R, Fishbein E, Palazuclos E, Aro A, Hernandez-Avila M. Unpublished data.
51. Cheng Y, Willett W, Schwartz J, Sparrow D, Weiss ST, Hu H. The relationship of nutrition to bone and blood lead levels in middle-aged to elderly men: the Normative Aging Study. Am J Epidemiol (in press).
52. Gerhardsson L, Chettle DR, Enelyst V, Nordberg GH, Nyhlin H, Scott MC, Todd AC, Vesterberg O. Kidney effects in long term exposed lead smelter workers. Br J Ind Med 49: 186-192 (1992).
53. Roels H, Lauwerys R, Konings J, Buchet J-P, Bernard A, Green S, Bradley D, Morgan W, Chettle D. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 51: 505-512 (1994).
54. Bellinger D, Hu H, Titlebaum L, Needleman HL. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 49: 98-105 (1994).
55. Needleman HI., Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA 275: 363-369 (1996).
56. Hu H, Watanabe H, Payton M, Korrick SA, Rotnitzky A. The relationship between bone lead and hemoglobin. JAMA 272: 1512-1517 (1994).
57. Hu H, Aro A, Pavton M, Korrick S, Sparrow D, Weiss ST, Rotnitzky A. The relationship of blood and bone lead to hypertension among middle-aged to elderly men. JAMA 275: 1171-1176 (1996).
58. Tyroler HA. Epidemiology of hypertension as a public health problem: an overview as background for evaluation of blood lead-blood pressure relationship. Environ Health Perspect 78: 3-7 (1988).
59. Korrick S, Hunter D, Rotnirzky A, Hu H, Speizer FE. Lead and Hypertension in a sample of middle-aged women. Am J Public Health (in press).
60. Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev 15: 352-373 (1993).
61. Payton M, Riggs KM, Spiro A, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. J Neurotoxicol Teratol 20: 19-27 (1998).
62. Bleecker ML, Linderen KN, Ford DP. Differential contribution of current and cumulative indices of lead dose to neuropsychological performances by age. Neurology 48: 639-645 (1997).
63. Cioruález-Cossio T, Peterson KE, Sanín L, Fishbein SE, Palazuelos E, Aro A, Hernández-Avila M, Hu H. Decrease in birrh weight in relation to maternal hone lead burden. Pediatrics 100: 856-862 (1997).
64. Gerhardsson L, Attewell R, Chortle DR, Englyst V, Lundström N-G, Nordberg GF, Nyhlin H, Scott MC, Todd AC. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health 48: 147-156 (1993).
65. Fleming DKB, Bolay D, Richard NS, Robin J-P, Gordon CL, Webber CE, Chettle DR. Accumulated body burden and endogenous release of lead in employees of a lead smelter. Environ Health Pcrspect 105: 224-233 (1997).